rs9394021
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020442.6(VARS2):c.2750G>A(p.Arg917Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,611,106 control chromosomes in the GnomAD database, including 45,951 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_020442.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VARS2 | NM_020442.6 | c.2750G>A | p.Arg917Gln | missense_variant | Exon 27 of 30 | ENST00000676266.1 | NP_065175.4 | |
VARS2 | NM_001167734.2 | c.2840G>A | p.Arg947Gln | missense_variant | Exon 27 of 30 | NP_001161206.1 | ||
VARS2 | NM_001167733.3 | c.2330G>A | p.Arg777Gln | missense_variant | Exon 26 of 29 | NP_001161205.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.241 AC: 36668AN: 152074Hom.: 5278 Cov.: 33
GnomAD3 exomes AF: 0.294 AC: 71014AN: 241804Hom.: 13202 AF XY: 0.291 AC XY: 38502AN XY: 132374
GnomAD4 exome AF: 0.208 AC: 303230AN: 1458914Hom.: 40659 Cov.: 34 AF XY: 0.214 AC XY: 155213AN XY: 725604
GnomAD4 genome AF: 0.241 AC: 36708AN: 152192Hom.: 5292 Cov.: 33 AF XY: 0.252 AC XY: 18769AN XY: 74402
ClinVar
Submissions by phenotype
not specified Benign:2
This variant is classified as Benign based on local population frequency. This variant was detected in 59% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 55. Only high quality variants are reported. -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Combined oxidative phosphorylation defect type 20 Benign:2
- -
- -
not provided Benign:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at